[Clinical observation of mucoregulatory agents' application after chronic rhinosinusitis surgery]

Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2011 Oct;25(20):922-4.
[Article in Chinese]

Abstract

Objective: To explore the effect of mucoregulatory agents during endoscopic sinus surgery.

Method: Ninety-seven cases with chronic rhinosinusitis were randomly divided into three groups, with 31 cases in B group treated by ambroxol, 33 cases in C group treated by eucalyptol-limonene-pinene enteric soft capsule and 33 cases in control group (A group). The follow-up visit lasted for 6 months for three groups. Then, the therapeutic effects were evaluated and compared among these three groups.

Result: By the end of 6 months after treatment,the effective rate was 90.3% and 97.0% for cases in the B and C groups respectively, and only 75.8% in A group. The difference between A and C was statistically significant (P < 0.05).

Conclusion: Eucalyptol-limonene-pinene enteric soft capsule,as a multicomponent mucoregulatory agent, can obviously improve the secretion of mucosa and epithelial recovery, thus accelerate healing of the disease. It can also improve the success rate of functional endoscope sinus surgery, and may play a promising role in clinical application.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Ambroxol / therapeutic use*
  • Chronic Disease
  • Cyclohexanols / therapeutic use*
  • Cyclohexenes / therapeutic use*
  • Eucalyptol
  • Expectorants / therapeutic use*
  • Female
  • Humans
  • Intraoperative Period
  • Limonene
  • Male
  • Middle Aged
  • Monoterpenes / therapeutic use*
  • Sinusitis / drug therapy*
  • Terpenes / therapeutic use*
  • Treatment Outcome
  • Young Adult

Substances

  • Cyclohexanols
  • Cyclohexenes
  • Expectorants
  • Monoterpenes
  • Terpenes
  • Ambroxol
  • Limonene
  • Eucalyptol